RICCIARDI, GIUSEPPINA ROSARIA
 Distribuzione geografica
Continente #
EU - Europa 1.710
NA - Nord America 1.284
AS - Asia 665
SA - Sud America 208
AF - Africa 28
OC - Oceania 1
Totale 3.896
Nazione #
US - Stati Uniti d'America 1.261
RU - Federazione Russa 955
SG - Singapore 255
CN - Cina 218
BR - Brasile 175
IE - Irlanda 175
SE - Svezia 174
IT - Italia 99
HK - Hong Kong 69
FR - Francia 58
DE - Germania 49
GB - Regno Unito 42
FI - Finlandia 39
IN - India 34
PL - Polonia 34
VN - Vietnam 33
UA - Ucraina 21
AT - Austria 20
BE - Belgio 19
AR - Argentina 12
CA - Canada 11
ZA - Sudafrica 10
CO - Colombia 9
ID - Indonesia 9
BD - Bangladesh 8
MX - Messico 8
TR - Turchia 8
MA - Marocco 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
EC - Ecuador 4
ES - Italia 4
NL - Olanda 4
PK - Pakistan 4
DZ - Algeria 3
JP - Giappone 3
KE - Kenya 3
LT - Lituania 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
EG - Egitto 2
GR - Grecia 2
IR - Iran 2
LV - Lettonia 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
PY - Paraguay 2
VE - Venezuela 2
AO - Angola 1
AU - Australia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
IM - Isola di Man 1
KG - Kirghizistan 1
KR - Corea 1
LK - Sri Lanka 1
ML - Mali 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
RO - Romania 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 3.896
Città #
Moscow 270
Ashburn 215
Dublin 174
Chandler 159
Singapore 146
Dallas 141
Nyköping 86
Beijing 85
Hong Kong 69
Jacksonville 54
Ann Arbor 52
The Dalles 51
San Jose 40
Los Angeles 36
New York 36
Messina 32
Warsaw 32
Princeton 25
Medford 24
Cambridge 23
Lauterbourg 21
Munich 21
Brussels 19
Dearborn 18
Des Moines 18
Pune 18
Vienna 18
Tianjin 14
Boardman 13
Buffalo 13
São Paulo 12
Woodbridge 12
Ho Chi Minh City 9
Jinan 9
Lancaster 8
Milan 8
Nanjing 8
San Mateo 8
Hanoi 7
Manchester 7
Turku 7
Chennai 6
Council Bluffs 6
Helsinki 6
Phoenix 6
Redondo Beach 6
Wilmington 6
Dong Ket 5
Frankfurt am Main 5
Johannesburg 5
Orem 5
Poplar 5
Shanghai 5
Stockholm 5
Ankara 4
Denver 4
Giardini-Naxos 4
Hangzhou 4
Hebei 4
Jakarta 4
Leawood 4
Montreal 4
Orta di Atella 4
Shenyang 4
Bogotá 3
Bremen 3
Campinas 3
Casablanca 3
Duque de Caxias 3
Fuzhou 3
Goiânia 3
Houston 3
Istanbul 3
Jiaxing 3
Joinville 3
London 3
Medellín 3
Mexico City 3
Montes Claros 3
Mumbai 3
Nairobi 3
Nanchang 3
Ningbo 3
Olomouc 3
Ribeirão Preto 3
Rio de Janeiro 3
Roubaix 3
Shenzhen 3
São Bernardo do Campo 3
Tashkent 3
Toronto 3
Trepuzzi 3
Washington 3
Amsterdam 2
Araçatuba 2
Asunción 2
Athens 2
Barbacena 2
Barnet 2
Bekasi 2
Totale 2.230
Nome #
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 238
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. 216
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients 215
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). 208
Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis. 191
Folate pathway implications in advanced Non Small Cell Lung Cancer (NSCLC): impact of thymidylate synthase (TS) promoter and methlylenetetrahydrofolate reductase (MTHFR) C677T and A1298C variants expression on patients’ outcome and correlation with p53 codon 72 mutations. 187
Preliminary study of pre-metastatic niche (PMN) in nonmetastatic nodes for the assessment of metastasis risk in breast cancer (BC). 178
Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. 171
Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. 170
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications. 168
Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study. 154
Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation. 152
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) 146
The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy 142
Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience. 134
Uncommon breast metastatic site and eribulin responsiveness in a heavily pretreated patient 132
Observational study to evaluate the pattern of trastuzumab (T) use and survival outcomes in HER2-positive (HER2+) early breast cancer (EBC): Regional Southern Italy experience. 123
Infra-centimetric HER2 positive Breast Cancer: The Southern Italy Experience. 121
Multicenter study in women with infracentimetric HER2 positive breast cancer: The Regional Sicilian experience. 120
Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience. 116
Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series. 112
Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectives. 108
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals 98
Safety of trastuzumab-containing therapies in elderly women with metastatic breast cancer. 95
null 72
The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population. 59
null 52
Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes 30
null 22
Totale 3.930
Categoria #
all - tutte 11.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.828


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 0 0 0 22 25 13
2021/2022189 3 21 5 5 3 4 10 6 3 47 23 59
2022/2023551 39 61 21 45 47 63 9 33 218 1 11 3
2023/2024203 7 21 11 12 9 70 57 2 2 3 2 7
2024/2025539 5 6 9 30 20 33 8 103 143 38 54 90
2025/20261.936 107 123 138 113 152 434 259 286 259 65 0 0
Totale 3.930